+1 347 708 0418
Trastuzumab Biosimilar market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Trastuzumab Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
Others
Segment by Application
Hospital Pharmacy
Online Pharmacy
By Company
Amgen Inc.
Pfizer Inc
Samsung Bioepis
Merck & Co.
Biocon Limited
Teva Pharmaceutical
Genentech
Mundipharma
Celltrion
Henlius
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Trastuzumab Biosimilar Product Introduction
1.2 Market by Type
1.2.1 Global Trastuzumab Biosimilar Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adjuvant Breast Cancer
1.2.3 Metastatic Breast Cancer
1.2.4 Metastatic Gastric Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Trastuzumab Biosimilar Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Trastuzumab Biosimilar Sales Estimates and Forecasts 2017-2028
2.2 Global Trastuzumab Biosimilar Revenue Estimates and Forecasts 2017-2028
2.3 Global Trastuzumab Biosimilar Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Trastuzumab Biosimilar Sales by Region
2.4.1 Global Trastuzumab Biosimilar Sales by Region (2017-2022)
2.4.2 Global Sales Trastuzumab Biosimilar by Region (2023-2028)
2.5 Global Trastuzumab Biosimilar Revenue by Region
2.5.1 Global Trastuzumab Biosimilar Revenue by Region (2017-2022)
2.5.2 Global Trastuzumab Biosimilar Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Trastuzumab Biosimilar Sales by Manufacturers
3.1.1 Global Top Trastuzumab Biosimilar Manufacturers by Sales (2017-2022)
3.1.2 Global Trastuzumab Biosimilar Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Trastuzumab Biosimilar in 2021
3.2 Global Trastuzumab Biosimilar Revenue by Manufacturers
3.2.1 Global Trastuzumab Biosimilar Revenue by Manufacturers (2017-2022)
3.2.2 Global Trastuzumab Biosimilar Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Trastuzumab Biosimilar Revenue in 2021
3.3 Global Trastuzumab Biosimilar Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Trastuzumab Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Trastuzumab Biosimilar Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Trastuzumab Biosimilar Sales by Type
4.1.1 Global Trastuzumab Biosimilar Historical Sales by Type (2017-2022)
4.1.2 Global Trastuzumab Biosimilar Forecasted Sales by Type (2023-2028)
4.1.3 Global Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
4.2 Global Trastuzumab Biosimilar Revenue by Type
4.2.1 Global Trastuzumab Biosimilar Historical Revenue by Type (2017-2022)
4.2.2 Global Trastuzumab Biosimilar Forecasted Revenue by Type (2023-2028)
4.2.3 Global Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
4.3 Global Trastuzumab Biosimilar Price by Type
4.3.1 Global Trastuzumab Biosimilar Price by Type (2017-2022)
4.3.2 Global Trastuzumab Biosimilar Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Trastuzumab Biosimilar Sales by Application
5.1.1 Global Trastuzumab Biosimilar Historical Sales by Application (2017-2022)
5.1.2 Global Trastuzumab Biosimilar Forecasted Sales by Application (2023-2028)
5.1.3 Global Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
5.2 Global Trastuzumab Biosimilar Revenue by Application
5.2.1 Global Trastuzumab Biosimilar Historical Revenue by Application (2017-2022)
5.2.2 Global Trastuzumab Biosimilar Forecasted Revenue by Application (2023-2028)
5.2.3 Global Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
5.3 Global Trastuzumab Biosimilar Price by Application
5.3.1 Global Trastuzumab Biosimilar Price by Application (2017-2022)
5.3.2 Global Trastuzumab Biosimilar Price Forecast by Application (2023-2028)
6 North America
6.1 North America Trastuzumab Biosimilar Market Size by Type
6.1.1 North America Trastuzumab Biosimilar Sales by Type (2017-2028)
6.1.2 North America Trastuzumab Biosimilar Revenue by Type (2017-2028)
6.2 North America Trastuzumab Biosimilar Market Size by Application
6.2.1 North America Trastuzumab Biosimilar Sales by Application (2017-2028)
6.2.2 North America Trastuzumab Biosimilar Revenue by Application (2017-2028)
6.3 North America Trastuzumab Biosimilar Market Size by Country
6.3.1 North America Trastuzumab Biosimilar Sales by Country (2017-2028)
6.3.2 North America Trastuzumab Biosimilar Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Trastuzumab Biosimilar Market Size by Type
7.1.1 Europe Trastuzumab Biosimilar Sales by Type (2017-2028)
7.1.2 Europe Trastuzumab Biosimilar Revenue by Type (2017-2028)
7.2 Europe Trastuzumab Biosimilar Market Size by Application
7.2.1 Europe Trastuzumab Biosimilar Sales by Application (2017-2028)
7.2.2 Europe Trastuzumab Biosimilar Revenue by Application (2017-2028)
7.3 Europe Trastuzumab Biosimilar Market Size by Country
7.3.1 Europe Trastuzumab Biosimilar Sales by Country (2017-2028)
7.3.2 Europe Trastuzumab Biosimilar Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Trastuzumab Biosimilar Market Size by Type
8.1.1 Asia Pacific Trastuzumab Biosimilar Sales by Type (2017-2028)
8.1.2 Asia Pacific Trastuzumab Biosimilar Revenue by Type (2017-2028)
8.2 Asia Pacific Trastuzumab Biosimilar Market Size by Application
8.2.1 Asia Pacific Trastuzumab Biosimilar Sales by Application (2017-2028)
8.2.2 Asia Pacific Trastuzumab Biosimilar Revenue by Application (2017-2028)
8.3 Asia Pacific Trastuzumab Biosimilar Market Size by Region
8.3.1 Asia Pacific Trastuzumab Biosimilar Sales by Region (2017-2028)
8.3.2 Asia Pacific Trastuzumab Biosimilar Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Trastuzumab Biosimilar Market Size by Type
9.1.1 Latin America Trastuzumab Biosimilar Sales by Type (2017-2028)
9.1.2 Latin America Trastuzumab Biosimilar Revenue by Type (2017-2028)
9.2 Latin America Trastuzumab Biosimilar Market Size by Application
9.2.1 Latin America Trastuzumab Biosimilar Sales by Application (2017-2028)
9.2.2 Latin America Trastuzumab Biosimilar Revenue by Application (2017-2028)
9.3 Latin America Trastuzumab Biosimilar Market Size by Country
9.3.1 Latin America Trastuzumab Biosimilar Sales by Country (2017-2028)
9.3.2 Latin America Trastuzumab Biosimilar Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Trastuzumab Biosimilar Market Size by Type
10.1.1 Middle East and Africa Trastuzumab Biosimilar Sales by Type (2017-2028)
10.1.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Type (2017-2028)
10.2 Middle East and Africa Trastuzumab Biosimilar Market Size by Application
10.2.1 Middle East and Africa Trastuzumab Biosimilar Sales by Application (2017-2028)
10.2.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Application (2017-2028)
10.3 Middle East and Africa Trastuzumab Biosimilar Market Size by Country
10.3.1 Middle East and Africa Trastuzumab Biosimilar Sales by Country (2017-2028)
10.3.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Corporation Information
11.1.2 Amgen Inc. Overview
11.1.3 Amgen Inc. Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen Inc. Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Inc. Recent Developments
11.2 Pfizer Inc
11.2.1 Pfizer Inc Corporation Information
11.2.2 Pfizer Inc Overview
11.2.3 Pfizer Inc Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Inc Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Inc Recent Developments
11.3 Samsung Bioepis
11.3.1 Samsung Bioepis Corporation Information
11.3.2 Samsung Bioepis Overview
11.3.3 Samsung Bioepis Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Samsung Bioepis Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Samsung Bioepis Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Overview
11.4.3 Merck & Co. Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck & Co. Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co. Recent Developments
11.5 Biocon Limited
11.5.1 Biocon Limited Corporation Information
11.5.2 Biocon Limited Overview
11.5.3 Biocon Limited Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biocon Limited Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biocon Limited Recent Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Overview
11.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Recent Developments
11.7 Genentech
11.7.1 Genentech Corporation Information
11.7.2 Genentech Overview
11.7.3 Genentech Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Genentech Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Genentech Recent Developments
11.8 Mundipharma
11.8.1 Mundipharma Corporation Information
11.8.2 Mundipharma Overview
11.8.3 Mundipharma Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mundipharma Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mundipharma Recent Developments
11.9 Celltrion
11.9.1 Celltrion Corporation Information
11.9.2 Celltrion Overview
11.9.3 Celltrion Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Celltrion Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Celltrion Recent Developments
11.10 Henlius
11.10.1 Henlius Corporation Information
11.10.2 Henlius Overview
11.10.3 Henlius Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Henlius Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Henlius Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Trastuzumab Biosimilar Industry Chain Analysis
12.2 Trastuzumab Biosimilar Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Trastuzumab Biosimilar Production Mode & Process
12.4 Trastuzumab Biosimilar Sales and Marketing
12.4.1 Trastuzumab Biosimilar Sales Channels
12.4.2 Trastuzumab Biosimilar Distributors
12.5 Trastuzumab Biosimilar Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Trastuzumab Biosimilar Industry Trends
13.2 Trastuzumab Biosimilar Market Drivers
13.3 Trastuzumab Biosimilar Market Challenges
13.4 Trastuzumab Biosimilar Market Restraints
14 Key Findings in The Global Trastuzumab Biosimilar Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Trastuzumab Biosimilar Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Adjuvant Breast Cancer
Table 3. Major Manufacturers of Metastatic Breast Cancer
Table 4. Major Manufacturers of Metastatic Gastric Cancer
Table 5. Major Manufacturers of Others
Table 6. Global Trastuzumab Biosimilar Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Trastuzumab Biosimilar Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Trastuzumab Biosimilar Sales by Region (2017-2022) & (K Units)
Table 9. Global Trastuzumab Biosimilar Sales Market Share by Region (2017-2022)
Table 10. Global Trastuzumab Biosimilar Sales by Region (2023-2028) & (K Units)
Table 11. Global Trastuzumab Biosimilar Sales Market Share by Region (2023-2028)
Table 12. Global Trastuzumab Biosimilar Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Trastuzumab Biosimilar Revenue Market Share by Region (2017-2022)
Table 14. Global Trastuzumab Biosimilar Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Trastuzumab Biosimilar Revenue Market Share by Region (2023-2028)
Table 16. Global Trastuzumab Biosimilar Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Trastuzumab Biosimilar Sales Share by Manufacturers (2017-2022)
Table 18. Global Trastuzumab Biosimilar Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Trastuzumab Biosimilar Revenue Share by Manufacturers (2017-2022)
Table 20. Trastuzumab Biosimilar Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Trastuzumab Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Trastuzumab Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trastuzumab Biosimilar as of 2021)
Table 23. Trastuzumab Biosimilar Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Trastuzumab Biosimilar Product Offered
Table 25. Date of Manufacturers Enter into Trastuzumab Biosimilar Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Trastuzumab Biosimilar Sales by Type (2017-2022) & (K Units)
Table 28. Global Trastuzumab Biosimilar Sales by Type (2023-2028) & (K Units)
Table 29. Global Trastuzumab Biosimilar Sales Share by Type (2017-2022)
Table 30. Global Trastuzumab Biosimilar Sales Share by Type (2023-2028)
Table 31. Global Trastuzumab Biosimilar Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Trastuzumab Biosimilar Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Trastuzumab Biosimilar Revenue Share by Type (2017-2022)
Table 34. Global Trastuzumab Biosimilar Revenue Share by Type (2023-2028)
Table 35. Trastuzumab Biosimilar Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Trastuzumab Biosimilar Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Trastuzumab Biosimilar Sales by Application (2017-2022) & (K Units)
Table 38. Global Trastuzumab Biosimilar Sales by Application (2023-2028) & (K Units)
Table 39. Global Trastuzumab Biosimilar Sales Share by Application (2017-2022)
Table 40. Global Trastuzumab Biosimilar Sales Share by Application (2023-2028)
Table 41. Global Trastuzumab Biosimilar Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Trastuzumab Biosimilar Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Trastuzumab Biosimilar Revenue Share by Application (2017-2022)
Table 44. Global Trastuzumab Biosimilar Revenue Share by Application (2023-2028)
Table 45. Trastuzumab Biosimilar Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Trastuzumab Biosimilar Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Trastuzumab Biosimilar Sales by Type (2017-2022) & (K Units)
Table 48. North America Trastuzumab Biosimilar Sales by Type (2023-2028) & (K Units)
Table 49. North America Trastuzumab Biosimilar Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Trastuzumab Biosimilar Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Trastuzumab Biosimilar Sales by Application (2017-2022) & (K Units)
Table 52. North America Trastuzumab Biosimilar Sales by Application (2023-2028) & (K Units)
Table 53. North America Trastuzumab Biosimilar Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Trastuzumab Biosimilar Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Trastuzumab Biosimilar Sales by Country (2017-2022) & (K Units)
Table 56. North America Trastuzumab Biosimilar Sales by Country (2023-2028) & (K Units)
Table 57. North America Trastuzumab Biosimilar Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Trastuzumab Biosimilar Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Trastuzumab Biosimilar Sales by Type (2017-2022) & (K Units)
Table 60. Europe Trastuzumab Biosimilar Sales by Type (2023-2028) & (K Units)
Table 61. Europe Trastuzumab Biosimilar Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Trastuzumab Biosimilar Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Trastuzumab Biosimilar Sales by Application (2017-2022) & (K Units)
Table 64. Europe Trastuzumab Biosimilar Sales by Application (2023-2028) & (K Units)
Table 65. Europe Trastuzumab Biosimilar Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Trastuzumab Biosimilar Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Trastuzumab Biosimilar Sales by Country (2017-2022) & (K Units)
Table 68. Europe Trastuzumab Biosimilar Sales by Country (2023-2028) & (K Units)
Table 69. Europe Trastuzumab Biosimilar Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Trastuzumab Biosimilar Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Trastuzumab Biosimilar Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Trastuzumab Biosimilar Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Trastuzumab Biosimilar Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Trastuzumab Biosimilar Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Trastuzumab Biosimilar Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Trastuzumab Biosimilar Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Trastuzumab Biosimilar Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Trastuzumab Biosimilar Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Trastuzumab Biosimilar Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Trastuzumab Biosimilar Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Trastuzumab Biosimilar Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Trastuzumab Biosimilar Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Trastuzumab Biosimilar Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Trastuzumab Biosimilar Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Trastuzumab Biosimilar Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Trastuzumab Biosimilar Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Trastuzumab Biosimilar Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Trastuzumab Biosimilar Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Trastuzumab Biosimilar Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Trastuzumab Biosimilar Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Trastuzumab Biosimilar Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Trastuzumab Biosimilar Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Trastuzumab Biosimilar Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Trastuzumab Biosimilar Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Trastuzumab Biosimilar Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Trastuzumab Biosimilar Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Trastuzumab Biosimilar Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Trastuzumab Biosimilar Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Trastuzumab Biosimilar Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Trastuzumab Biosimilar Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Trastuzumab Biosimilar Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Trastuzumab Biosimilar Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Trastuzumab Biosimilar Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Trastuzumab Biosimilar Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Trastuzumab Biosimilar Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Trastuzumab Biosimilar Revenue by Country (2023-2028) & (US$ Million)
Table 107. Amgen Inc. Corporation Information
Table 108. Amgen Inc. Description and Major Businesses
Table 109. Amgen Inc. Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Amgen Inc. Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Amgen Inc. Recent Developments
Table 112. Pfizer Inc Corporation Information
Table 113. Pfizer Inc Description and Major Businesses
Table 114. Pfizer Inc Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Pfizer Inc Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Inc Recent Developments
Table 117. Samsung Bioepis Corporation Information
Table 118. Samsung Bioepis Description and Major Businesses
Table 119. Samsung Bioepis Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Samsung Bioepis Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Samsung Bioepis Recent Developments
Table 122. Merck & Co. Corporation Information
Table 123. Merck & Co. Description and Major Businesses
Table 124. Merck & Co. Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Merck & Co. Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Merck & Co. Recent Developments
Table 127. Biocon Limited Corporation Information
Table 128. Biocon Limited Description and Major Businesses
Table 129. Biocon Limited Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Biocon Limited Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biocon Limited Recent Developments
Table 132. Teva Pharmaceutical Corporation Information
Table 133. Teva Pharmaceutical Description and Major Businesses
Table 134. Teva Pharmaceutical Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Teva Pharmaceutical Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Teva Pharmaceutical Recent Developments
Table 137. Genentech Corporation Information
Table 138. Genentech Description and Major Businesses
Table 139. Genentech Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Genentech Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Genentech Recent Developments
Table 142. Mundipharma Corporation Information
Table 143. Mundipharma Description and Major Businesses
Table 144. Mundipharma Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Mundipharma Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Mundipharma Recent Developments
Table 147. Celltrion Corporation Information
Table 148. Celltrion Description and Major Businesses
Table 149. Celltrion Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Celltrion Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Celltrion Recent Developments
Table 152. Henlius Corporation Information
Table 153. Henlius Description and Major Businesses
Table 154. Henlius Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Henlius Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Henlius Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Trastuzumab Biosimilar Distributors List
Table 160. Trastuzumab Biosimilar Customers List
Table 161. Trastuzumab Biosimilar Market Trends
Table 162. Trastuzumab Biosimilar Market Drivers
Table 163. Trastuzumab Biosimilar Market Challenges
Table 164. Trastuzumab Biosimilar Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Trastuzumab Biosimilar Product Picture
Figure 3. Global Trastuzumab Biosimilar Market Share by Type in 2021 & 2028
Figure 3. Adjuvant Breast Cancer Product Picture
Figure 4. Metastatic Breast Cancer Product Picture
Figure 5. Metastatic Gastric Cancer Product Picture
Figure 6. Others Product Picture
Figure 7. Global Trastuzumab Biosimilar Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacy
Figure 9. Online Pharmacy
Figure 10. Trastuzumab Biosimilar Report Years Considered
Figure 11. Global Trastuzumab Biosimilar Sales 2017-2028 (K Units)
Figure 12. Global Trastuzumab Biosimilar Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Trastuzumab Biosimilar Revenue 2017-2028 (US$ Million)
Figure 14. Global Trastuzumab Biosimilar Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Trastuzumab Biosimilar Sales Market Share by Region (2017-2022)
Figure 16. Global Trastuzumab Biosimilar Sales Market Share by Region (2023-2028)
Figure 17. North America Trastuzumab Biosimilar Sales YoY (2017-2028) & (K Units)
Figure 18. North America Trastuzumab Biosimilar Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Trastuzumab Biosimilar Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Trastuzumab Biosimilar Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Trastuzumab Biosimilar Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Trastuzumab Biosimilar Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Trastuzumab Biosimilar Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Trastuzumab Biosimilar Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Trastuzumab Biosimilar Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Trastuzumab Biosimilar Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Trastuzumab Biosimilar Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Trastuzumab Biosimilar in the World: Market Share by Trastuzumab Biosimilar Revenue in 2021
Figure 29. Global Trastuzumab Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
Figure 31. Global Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
Figure 32. Global Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
Figure 33. Global Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
Figure 34. North America Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
Figure 35. North America Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
Figure 36. North America Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
Figure 37. North America Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
Figure 38. North America Trastuzumab Biosimilar Sales Share by Country (2017-2028)
Figure 39. North America Trastuzumab Biosimilar Revenue Share by Country (2017-2028)
Figure 40. United States Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
Figure 43. Europe Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
Figure 44. Europe Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
Figure 45. Europe Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
Figure 46. Europe Trastuzumab Biosimilar Sales Share by Country (2017-2028)
Figure 47. Europe Trastuzumab Biosimilar Revenue Share by Country (2017-2028)
Figure 48. Germany Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 49. France Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Trastuzumab Biosimilar Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Trastuzumab Biosimilar Revenue Share by Region (2017-2028)
Figure 59. China Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 62. India Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
Figure 69. Latin America Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
Figure 71. Latin America Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Trastuzumab Biosimilar Sales Share by Country (2017-2028)
Figure 73. Latin America Trastuzumab Biosimilar Revenue Share by Country (2017-2028)
Figure 74. Mexico Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Trastuzumab Biosimilar Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Trastuzumab Biosimilar Revenue Share by Country (2017-2028)
Figure 83. Turkey Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Trastuzumab Biosimilar Revenue (2017-2028) & (US$ Million)
Figure 86. Trastuzumab Biosimilar Value Chain
Figure 87. Trastuzumab Biosimilar Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Buy
